NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02289989,Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02289989,,TERMINATED,"This study is designed to evaluate and compare the efficacy of 3% oregano extract ointment prepared in aqueous solution versus 1% hydrocortisone ointment, a standard treatment, in decreasing the inflammation associated with mild to moderate atopic dermatitis. We plan to recruit 40 patients on the ages comprised between 2 and 17 years old and the study duration for each of the patient is 1 month.",YES,Atopic Dermatitis,DRUG: Oregano extract cream|DRUG: Hydrocortisone,"The Clinical Efficacy Rated by the Patient or Caregiver on Days 0 and 25, This was measured with two questions. The first one referred to the description of the lesion and it included six characteristics: clear, dry, scaly, redness, cracks/opening and oozing. The second questions asked to grade how itchy was the patient.

All characteristics were measured on a scale from 0 to 5 (0 none, 5 extremely bothered/losing sleep)., From baseline to day 25|Change of the Clinical Efficacy Rated by a Study Physician, Physician was asked to grade four characteristics: erythema, infiltration/papulation, excoriation and lichenification. The grade was none (0), mild (1), moderate (2) and severe (3)., Baseline to day 28|Histological Improvement Measured by Confocal Microscopy, Confocal microscopy was done to the patient on day 0, day 14 and day 28. Due to technical difficulties, this outcome measure was not collected., Baseline to day 28","Measure Presence of S. Aureus Colonization on Affected Skin, Bacterial culture of the affected area was done on day 0 and day 14., Baseline to day 14|Rate Cosmetic Acceptability of Topical Agents, The patient or caregiver rated how the product felt on their skin after applying the product, measuring the cosmetic acceptability on day 7 and 14. The scale was excellent, good, moderate and poor., On day 7 and 14|Rate Skin Tolerance of Topical Agents, The patient or caregiver rated how well the patient tolerated the product after applying it on day 7 and 14. The scale was excellent, good, moderate and poor., On day 7 and 14",,"Rutgers, The State University of New Jersey",,ALL,CHILD,NA,1,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",Pro2012002449,2014-11,2017-01,2017-01,2014-11-13,2017-02-06,2017-05-10,"Department of Dermatology. Rutgers-RWJMS, Somerset, New Jersey, 08873, United States",
